Noxon Israeli Company

Noxon develops a novel drug for oral treatment of fibrotic lung diseases. The developed drug, 3-cabamoyl-proxyl, is a stable organic radical belonging to the nitroxides group.

Health Tech & Life Sciences

Alternatives

No alternatives listed yet.

Suggest an Alternative

Name *

URL *

Office Locations

Nazareth, Israel

References

[1]

finder.startupnationcentral.org - https://finder.startupnationcentral.org/company_page/noxon

External links are provided for reference and verification purposes.